Medical Devices Startups
6,293 companies tagged Medical Devices, with their investors and founders.
LimFlow develops a medical device system for the treatment of chronic limb-threatening ischemia. The company is part of Inari Medical.
2 investors
LimiFlex develops the Dynamic Sagittal Tether, a spinal implant that stabilizes the lumbar spine after surgical decompression while preserving natural motion, positioned as an alternative to spinal fusion. It targets patients with grade I lumbar degenerative spondylolisthesis and spinal stenosis, serving spine surgeons in the medical device field.
2 investors
Linear Diagnostics develops near-patient (point-of-care) diagnostic technology using EXPAR that delivers results in under 15 minutes, initially focused on detecting sexually transmitted infections and other infectious diseases. Its rapid testing is aimed at STI clinics to enable immediate treatment and reduce onward transmission.
2 investors
Lineus Medical makes SafeBreak Vascular, a breakaway device that installs into vascular access lines (peripheral IVs, midlines, PICCs, central lines, ports, and interosseous access) and separates under harmful force, sealing both ends to prevent fluid loss and reduce IV restarts. It is FDA-cleared for adult and pediatric patients and is marketed to nurses and hospitals.
2 investors
Linshom Medical manufactures a wearable, FDA-cleared respiratory monitoring device that provides operating room quality respiratory data at the patient bedside, designed to detect early signs of respiratory problems and reduce adverse events in post-surgical and other patient care settings.
2 investors
LinusBio develops precision medicine diagnostics based on exposome sequencing to identify biomarkers for complex conditions including autism spectrum disorder, amyotrophic lateral sclerosis, inflammatory bowel disease, and other diseases. The company serves physicians and patients seeking earlier detection and intervention for conditions that historically lacked molecular diagnostic endpoints.
2 investors
Minos is an abdominal aortic stent graft device designed for endovascular aneurysm repair, featuring a tri-modular design with ultra-low profile delivery and helical stent limbs for deployment in aortic and iliac anatomy.
2 investors
Longeviti Neuro Solutions develops cranial implant platforms for complex brain surgery, including patient-specific and off-the-shelf implants that restore skull contour and enable real-time post-operative ultrasound imaging. Its products serve neurosurgeons and medical professionals treating patients with neurological conditions.
2 investors
Loop Genomics developed long-read sequencing technology that used synthetic long reads to enable full-length sequencing of DNA and RNA molecules on standard short-read sequencers. Acquired by Element Biosciences in 2021.
2 investors
LSK Technologies builds a portable distributed testing platform for diagnosing infectious diseases in field and remote settings. The device, called PLUM, enables rapid and decentralized diagnostic testing for pathogens like Zika virus and SARS-CoV-2.
2 investors
EQT Life Sciences (formerly LSP) is one of Europe's largest life sciences investment firms that invests in innovative companies developing therapeutics, medical devices, diagnostics, and healthtech solutions. The firm targets companies with the potential to address unmet clinical needs and improve patient outcomes, with a 30-year track record and approximately 3.5 billion euros raised across multiple funds.
2 investors
Lubricin (PRG4) is a glycoprotein found naturally in the human body that lubricates and protects tissue surfaces from friction and wear. The company develops recombinant lubricin as a therapeutic agent to address inflammation-related conditions like dry eye and osteoarthritis.
2 investors
Lucerna Dynamics provides software that identifies injection errors in nuclear medicine procedures, evaluates their impact, and helps reduce error frequency for healthcare teams.
2 investors
Lucidact provides nurse-led remote patient monitoring and virtual care for Medicare and Medicaid patients with chronic conditions such as hypertension, heart disease, and diabetes. Its platform supports member enrollment, clinical data monitoring, medication management, care coordination, SDOH screening, and billing for healthcare providers and organizations.
2 investors
Lumicell develops a fluorescence-guided intraoperative imaging technology, including its LUMISIGHT optical imaging agent, that illuminates cancerous tissue in the surgical cavity to help surgeons remove residual cancer during procedures such as lumpectomy. The platform is aimed at surgical oncology, starting with breast cancer, and its flagship product has received FDA approval.
2 investors
LUMICKS develops life science research tools that measure and apply forces around biological interactions to link structural and 'omics analysis to functional outcomes at the molecular and cellular level. Its instruments serve academic research, drug development, bioprocessing, and immuno-oncology markets.
2 investors
LumiraDx develops rapid point-of-care diagnostic tests run on its microfluidic immunofluorescence platform, including a SARS-CoV-2 antigen test that detects the virus from nasal and nasopharyngeal swab samples in about 12 minutes. The tests are intended for near-patient use by healthcare providers to aid in diagnosing COVID-19 infection.
2 investors
LumiThera develops the Valeda Light Delivery System, an FDA-authorized photobiomodulation (PBM) device that applies multiple light wavelengths to treat early and intermediate dry age-related macular degeneration (AMD). The non-invasive treatment is intended for eyecare practitioners to help patients maintain or improve visual acuity.
2 investors
Lungpacer Medical develops neurostimulation technologies for critical care, focused on ventilator weaning to improve outcomes for patients. Its offerings are built by a team of clinical and engineering experts.
2 investors
MACH32 is a start-up that develops medical devices, including products named IMSAFE and ACT. It is based in Edmonton, Canada.
2 investors
MacroLux Medical Technology develops endoscopic imaging systems and related medical devices. The company serves hospitals and medical institutions globally, with operations across Europe, North America, and Asia-Pacific regions.
2 investors
Madrigal Pharmaceuticals is a biopharmaceutical company developing treatments for metabolic-associated steatohepatitis (MASH). The company focuses on improving care for patients with this liver disease through innovative drug development and collaboration.
2 investors
Magnet Biomedicine develops TrueGlue™, a molecular glue discovery platform for designing small molecule therapeutics that induce novel protein-protein interactions to treat cancer and immune disorders. The platform systematically identifies molecular glues capable of targeting historically difficult-to-drug proteins in precision medicine.
2 investors
Marani develops maternity care technology to improve access to prenatal and obstetric care for expectant mothers and providers. The platform delivers pregnancy-specific insights to reduce maternal and infant health disparities in the United States.
2 investors